Skip to main content
DGP Co.,Ltd. logo

DGP Co.,Ltd. — Investor Relations & Filings

Ticker · 060900 ISIN · KR7060900008 KO Electricity, gas, steam and air conditioning supply
Open in API
Filings indexed 587 across all filing types
Latest filing 2019-03-14 Proxy Solicitation & In…
Country KR South Korea
Listing KO 060900

About DGP Co.,Ltd.

https://www.daehangreenpower.com/

DGP Co., Ltd. is an eco-friendly technology company specializing in renewable energy solutions. The company's primary activities involve the generation of electricity from diverse sources, including hydrogen, photovoltaic (solar), and wind power. It also operates in the bio-fuel sector and is expanding into battery and electricity-related businesses. DGP provides comprehensive services encompassing the engineering, procurement, and construction (EPC) of solar and wind power plants, as well as subsequent repair and maintenance. The company focuses on leveraging its proprietary technology and know-how to develop and deliver integrated, sustainable energy solutions.

Recent filings

Filing Released Lang Actions
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Pacific Bio. It outlines the date, location, and agenda items for the upcoming Annual General Meeting, including the approval of financial statements, election of directors, and remuneration limits. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the meeting's agenda and request their participation/votes.
2019-03-14 Korean
주주총회집중일개최사유신고
AGM Information Classification · 1% confidence The document is a formal regulatory filing submitted to the KRX (Korea Exchange) regarding the 'Reason for holding a General Meeting of Shareholders on a concentrated date'. It explains why the company is holding its AGM on a date that coincides with other companies' meetings. Since this is a regulatory disclosure regarding meeting logistics rather than the meeting materials themselves (AGM-R) or a proxy statement (PSI), it falls under the general regulatory filing category.
2019-03-14 Korean
주주총회소집공고
AGM Information Classification · 1% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Pacific Bio Co., Ltd. It details the meeting date, location, agenda items (financial statement approval, director appointments, etc.), and provides management reference materials (business overview, board activities, and financial outlook). This document is a standard proxy statement/notice package sent to shareholders to inform them of an upcoming Annual General Meeting (AGM) and solicit their votes. In the context of the provided categories, this aligns perfectly with Proxy Solicitation & Information Statement (PSI).
2019-03-14 Korean
매출액또는손익구조30%(대규모법인은15%)미만변동(자율공시)
Audit Report / Information Classification · 1% confidence The document is a regulatory filing from a Korean company (Pacific Bio) regarding a change in financial structure (revenue/profit) that is less than 30%. It provides a summary table of financial data (revenue, operating profit, net income) and explains the reasons for the change. Since this is a specific regulatory disclosure of financial results (often referred to as a 'voluntary disclosure' or 'autonomous disclosure' in the Korean market) and does not constitute a full annual or quarterly report, it falls under the general regulatory filing category. FY 2018
2019-03-06 Korean
전환가액의조정(제25회차)
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory filing from a Korean company (Pacific Bio) regarding the adjustment of the conversion price of convertible bonds (CB). This type of disclosure is a standard corporate action related to capital structure and financing instruments. Since it specifically details the adjustment of conversion prices and the resulting change in the number of convertible shares, it falls under the 'Capital/Financing Update' category.
2019-02-01 Korean
전환사채(해외전환사채포함)발행후만기전사채취득(제24회차)
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory disclosure regarding the acquisition of convertible bonds before maturity (Put Option exercise) by Pacific Bio. It details the bond series, acquisition amount, source of funds, and method of acquisition. This falls under capital structure and financing activities, specifically related to debt management, which is best classified as a Capital/Financing Update (CAP).
2018-12-27 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.